COMMUNIQUÉS West-GlobeNewswire

Neos Therapeutics Announces Settlement with Teva on Cotempla XR-ODT® Patent Litigation
26/12/2018
DALLAS and FORT WORTH, Texas, Dec. 26, 2018 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq:NEOS), a pharmaceutical company focused on developing, manufacturing, and commercializing innovative extended-release (XR) [...]
Myriad Announces Publication of Vectra® Study in Journal Rheumatology
26/12/2018
Adjusted Vectra Test Is Up to Five Times More Effective for Predicting Radiographic Progression in Patients with Rheumatoid Arthritis than Traditional Measures SALT LAKE CITY, Dec. 26, 2018 (GLOBE NEWSWIRE) -- Myriad [...]
Athenex Pharmaceutical Division, an Athenex, Inc. Company, Launches Levothyroxine Sodium for Injection
26/12/2018
BUFFALO, N.Y., Dec. 26, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc. (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of [...]
BrainStorm Expands Manufacturing of NurOwn® for Phase 2 Progressive MS Trial
26/12/2018
BrainStorm has contracted with the Connell and O'Reilly Families Cell Manipulation Core Facility at Dana-Farber Cancer Institute, currently supporting the Phase 3 ALS Trial, to Produce NurOwn® NEW YORK and BOSTON, Dec. [...]
Management Cease Trade Order Update
26/12/2018
HALIFAX, Nova Scotia, Dec. 25, 2018 (GLOBE NEWSWIRE) -- MedMira Inc. (TSXV: MIR) (“MedMira” or the “Company”) provides an update with respect to the previously announced management cease trade order (the “MCTO”) issued [...]
Opiant Pharmaceuticals, Inc. Announces FDA Orange Book Listing for New NARCAN® Nasal Spray Patent
24/12/2018
NARCAN Now Covered by Eight Orange Book-Listed Patents SANTA MONICA, Calif., Dec. 24, 2018 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a specialty pharmaceutical company developing [...]
Microbix Enhances Quality Management System
24/12/2018
ISO 13485:2016 Medical Devices Certification Attained TORONTO, Dec. 24, 2018 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of biological products and technologies, announces that it [...]
ProQR Therapeutics Added to NASDAQ Biotechnology Index
24/12/2018
LEIDEN, Netherlands & CAMBRIDGE, Mass., Dec. 24, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA medicines for the [...]
Canada House Receives Cannabis Sales License from Health Canada
24/12/2018
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Dec. 24, 2018 (GLOBE NEWSWIRE) -- Canada House Wellness Group Inc. (CSE: CHV) (“ Canada House ” or the “ Company ”) is [...]
MediPharm Labs Increases Annual Production Capacity by 50% Up to 150,000KG; Positioned to Meet Significant Demand for Purified Cannabis Concentrates and Oil
24/12/2018
MediPharm Labs Maintains Largest Cannabis Extraction-Only Footprint in Canada TORONTO, Dec. 24, 2018 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSXV: LABS) (the “ Company ” or “ MediPharm Labs ”) is pleased to announce [...]
Mesoblast to Present at 2019 Biotech Showcase in San Francisco
24/12/2018
NEW YORK and MELBOURNE, Australia, Dec. 24, 2018 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX:MSB; Nasdaq:MESO) will report on its Phase 3 trials and commercial plans at the upcoming Biotech Showcase 2019 to be held in [...]
Holding(s) in Company
24/12/2018
Holding(s) in Company December 24, 2018 – Shire plc (LSE: SHP, NASDAQ: SHPG) 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii : Shire Plc JE00B2QKY057 1b. [...]
Rule 2.9 Announcement
24/12/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 24 December 2018 [...]
PledPharma applies for an Orphan Drug Designation (ODD) in the US for Aladote
24/12/2018
Stockholm, December 24, 2018. PledPharma AB (publ) announces that the company has filed an application for an Orphan Drug Designation (ODD) to the US FDA for the drug candidate Aladote ® , developed to reduce liver [...]
Bone Therapeutics SA: Information on the total number of voting rights and shares
24/12/2018
Regulated information Gosselies, Belgium, 24 December 2018, 7am CEST – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the bone cell therapy company addressing high unmet medical needs in orthopaedics and bone [...]
Bone Therapeutics SA : Information relative au nombre total de droits de vote et d’actions
24/12/2018
Information réglementée Gosselies, Belgique, le 24 décembre 2018, 07h00 CEST - BONE THERAPEUTICS (code Euronext Bruxelles et Paris : BOTHE), société de thérapie cellulaire osseuse qui répond à d’importants besoins [...]
SoldierStrong Donates State-of-the-Art Exoskeleton to the St. Louis Veterans Health Care System
23/12/2018
ST. LOUIS, Dec. 22, 2018 (GLOBE NEWSWIRE) -- SoldierStrong, a national nonprofit organization dedicated to providing advanced medical technologies to veterans, donated an Indego Therapy exoskeleton to the St. Louis [...]
Rahal Automotive Group Donates $40,000 to SoldierStrong to Aid Military Veterans Rehabilitating From Spinal Injuries
22/12/2018
PITTSBURGH, Dec. 22, 2018 (GLOBE NEWSWIRE) -- Bobby Rahal Automotive Group today donated $40,000 to SoldierStrong, a national nonprofit organization that provides state-of-the-art medical devices to aid in [...]
Helix BioPharma Corp. Closes Third Tranche of Private Placement
21/12/2018
RICHMOND HILL, Ontario, Dec. 21, 2018 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX, FSE: “HBP”) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and [...]

Pages